Table 2.
Variables1 | Total sample (n = 190) |
Classification quadrants - BIVA
|
||||
Q1 (n = 91; 47.9%)
|
Q2 (n = 36; 18.9%)
|
Q3 (n = 27; 14.2%)
|
Q4 (n = 36; 18.9%)
|
P
value
|
||
Age (yr) | 56.6 ± 11.0 | 56.8 ± 9.64 | 50.3 ± 14.33 | 57.7 ± 9.24 | 61.6 ± 8.94 | < 0.001 |
Gender | 0.642 | |||||
Male | 116 (61.1) | 54 (59.3) | 20 (55.6) | 17 (63.0) | 25 (69.4) | |
Female | 74 (38.9) | 37 (40.7) | 16 (44.4) | 10 (37.0) | 11 (30.6) | |
Child-Turcotte-Pugh | 0.052 | |||||
A | 107 (56.3) | 52 (57.1) | 27 (75.0) | 13 (48.1) | 15 (41.7) | |
B | 48 (25.3) | 25 (27.5) | 5 (13.9) | 9 (33.3) | 9 (25.0) | |
C | 35 (18.4) | 14 (15.4) | 4 (11.1) | 5 (18.5) | 12 (33.3) | |
Etiology | 0.380 | |||||
HCV | 90 (47.4) | 45 (49.5) | 16 (44.4) | 13 (48.1) | 16 (44.4) | |
Alcohol | 51 (26.8) | 29 (31.9) | 7 (19.4) | 7 (25.9) | 8 (22.2) | |
HCV + alcohol | 21 (11.1) | 6 (6.6) | 4 (11.1) | 4 (14.8) | 7 (19.4) | |
Other2 | 28 (14.7) | 11 (12.1) | 9 (25.0) | 3 (11.1) | 5 (13.9) | |
Phase angle | 6.06 ± 2.20 | 6.49 ± 2.444 | 7.30 ± 2.124 | 5.07 ± 0.673 | 4.46 ± 0.703 | < 0.001 |
Described by mean ± SD or n (%).
Indicates hepatitis B virus, autoimmune, cholestatic disease, non-alcoholic fatty liver disease, and cryptogenic.
Numbers with superscript 3 do not differ statistically at 5% significance by Tukey’s test.
Numbers with superscript 4 do not differ statistically at 5% significance by Tukey’s test. BIVA: Bioelectrical impedance vector analysis; HCV: Hepatitis C virus; Q1: Quadrant 1; Q2: Quadrant 2; Q3: Quadrant 3; Q4: Quadrant 4.